切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2014, Vol. 08 ›› Issue (05) : 16 -18. doi: 10.3877/cma. j. issn.1674-0807.2014.05.004

论著

癌基因RhoA 对乳腺癌细胞血管内皮生长因子表达的调控机制研究
赵庆丽1,(), 马骥1   
  1. 1.730050 兰州,中国人民解放军兰州军区兰州总医院乳腺科
  • 收稿日期:2014-01-22 出版日期:2014-10-01
  • 通信作者: 赵庆丽
  • 基金资助:
    国家自然科学基金资助项目(81202085)

Regulatory mechanism of oncogene RhoA on the expression of vascular epithelial growth factor in breast cancer cells

Qingli Zhao1,(), Ji Ma1   

  1. 1.Department of Breast Diseases, Lanzhou General Hospital of PLA, Lanzhou 730000, China
  • Received:2014-01-22 Published:2014-10-01
  • Corresponding author: Qingli Zhao
引用本文:

赵庆丽, 马骥. 癌基因RhoA 对乳腺癌细胞血管内皮生长因子表达的调控机制研究[J/OL]. 中华乳腺病杂志(电子版), 2014, 08(05): 16-18.

Qingli Zhao, Ji Ma. Regulatory mechanism of oncogene RhoA on the expression of vascular epithelial growth factor in breast cancer cells[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2014, 08(05): 16-18.

目的

探讨乳腺癌细胞MDA-MB-231 中癌基因RhoA 对VEGF 蛋白表达和胞外分泌的影响及可能的分子机制。

方法

将RhoA 过表达质粒pcDNA3.0-V14RhoA、对照质粒pcDNA3.0、RhoA 沉默质粒pcDNA3.0-shRhoA 转染到MDA-MB-231 细胞中,通过Western blot 和ELISA 实验分别检测细胞内外VEGF 蛋白的表达,通过Western blot 和实时PCR 方法分别检测RhoA 对p53 表达的影响及对VEGF的调控作用。 均数比较用t 检验;计量资料用 表示,采用方差分析。

结果

MDA-MB-231 细胞中上调RhoA 表达后,胞内VEGF 的蛋白表达水平增加;胞外分泌水平显著增加,与对照组相比差异具有统计学意义(F=4.020,P=0.032);MDA-MB-231 细胞中沉默RhoA 表达后,胞内VEGF 的蛋白表达水平降低;胞外分泌水平显著降低,与对照组相比差异具有统计学意义(F=5.131,P=0.001);并且与0 h 相比,在MDA-MB-231 细胞中上调RhoA 可以抑制p53 的表达(48 h:F=3.231,P=0.043),而p53 表达的降低可以增加VEGF 的表达水平(48 h:F=3.226,P=0.015),均差异具有统计学意义。

结论

乳腺癌细胞MDA-MB-231 中RhoA 表达的变化可以引起胞内外VEGF 水平的变化,并且RhoA 可能是通过抑制p53的表达从而增加VEGF 表达。

Objective

To explore the effects of oncogene RhoA on protein expression of vascular epithelial growth factor(VEGF) and exocytosis in breast cancer cell line MDA-MB-231 and its potential molecular mechanism.

Methods

RhoA-overexpressed plasmid pcDNA3.0-V14RhoA, control plasmid pcDNA3.0 and RhoA-silencing plasmid pcDNA3.0-shRhoA were transfected into MDA-MB-231 cells. After that, VEGF protein expression was detected by Western blot and ELISA assay. The effects of RhoA on p53 expression and on VEGF regulation were examined by Western blot or real-time PCR. The means were compared using t text, and the measurement data were expressed as and processed using analysis of variance.

Results

After up-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly increased compared with the control group(F = 4.020,P =0.032), while after down-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly decreased compared with the control group(F = 5.131,P =0.001). Compared with the control group, the upregulation of RhoA could inhibit p53 expression (48 h:F=3.231,P=0.043)and the decrease of p53 expression could promote VEGF expression(48 h:F=3.226,P=0.015).

Conclusion

In breast cancer MDA-MB-231 cells, the change of RhoA expression can cause the change of intracellular and extracellular VEGF expression, and RhoA may promote VEGF expression through inhibiting p53 expression.

[1]
Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells[J]. Circ Res,2009,104(4):531-540.
[2]
Aspenström P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level:the cellular functions of atypical Rho GTPases[J]. Exp Cell Res,2007,313(17):3673-3679.
[3]
Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers[J]. Cancer,2010,116(11 Suppl):2768-2782.
[4]
Chang CC, Tsai SY, Lin H, et al. Aryl-hydrocarbon receptordependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene[J]. Cell Mol Life Sci,2009,66(19):3193-3205.
[5]
Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch[J]. Nat Rev Cancer,2003,3(6):401-410.
[6]
Ferrara N. Vascular endothelial growth factor[J]. Arterioscler Thromb Vasc Biol,2009,29(6):789-791.
[7]
Ogata S, Morishige K, Sawada K, et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells[J]. Int J Gynecol Cancer,2009,19(9):1473-1480.
[8]
Li H, Peng W, Jian W, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion [ J ].Cardiovasc Diabetol,2012,11:65.
[9]
Quartuccio SM, Lantvit DD, Bosland MC, et al. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas[J]. PLoS One, 2013,8(5):e65067
[10]
Zietz C, Rössle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation,and VEGF up-regulation in angiosarcomas[J]. Am J Pathol,1998,153(5):1425-1433.
[11]
Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma[J]. Cancer Res,2001,61(18):6952-6957.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
阅读次数
全文


摘要